LAZARD ASSET MANAGEMENT LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 23 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$4,620
-100.0%
8,400,000
-50.9%
0.01%
-57.1%
Q3 2022$9,629,000
+1.7%
17,100,0000.0%0.01%
+7.7%
Q2 2022$9,469,000
-3.8%
17,100,000
-10.5%
0.01%
+18.2%
Q1 2022$9,848,000
-23.2%
19,100,000
-21.4%
0.01%
-21.4%
Q4 2021$12,818,00024,300,0000.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 17,454,000$9,8263.09%
Affinity Asset Advisors, LLC 7,500,000$3,008,2500.99%
DCF Advisers, LLC 3,600,000$1,476,0000.90%
Context Capital Management, LLC 21,851$8,7640.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 32,000,000$13,1200.48%
SILVERBACK ASSET MANAGEMENT LLC 6,250,000$2,500,0000.34%
WHITEBOX ADVISORS LLC 20,600,000$8,159,6600.28%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,425,000$11,431,7480.23%
READYSTATE ASSET MANAGEMENT LP 5,500,000$2,206,0500.20%
DAVIDSON KEMPNER PARTNERS 25,000,000$9,432,5000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders